Drug profile · INN
dasiglucagon hydrochloride
ZEGALOGUE
dasiglucagon hydrochloride (ZEGALOGUE) is a glucagon receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — dasiglucagon hydrochloride
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
dasiglucagon hydrochloride (ZEGALOGUE) is a glucagon receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucagon receptor agonist
Primary target: Glucagon receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dasiglucagon hydrochloride?
dasiglucagon hydrochloride (ZEGALOGUE) is a glucagon receptor agonist. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for dasiglucagon hydrochloride?
ZEGALOGUE is a marketed brand name for dasiglucagon hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dasiglucagon hydrochloride?
dasiglucagon hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.